Currently viewing: | Who we are | Next: Leadership reviews
Currently viewing: | Who we are | Next: Leadership reviews
At Aspen, we believe everyone should have access to high quality, affordable medicines to live a healthy and fulfilled life.
Through our industry position as a global pharmaceutical company, with a relevant portfolio of medicines and strategic manufacturing capability, we contribute to furthering the World Health Organization’s (“WHO’s”) goal of Universal Health Care Coverage and advancing the outcomes of the United Nations SDG3 of “ensuring healthy lives and promoting well-being for all at all ages”. Aligned to our ethos Healthcare. We Care. we strive to improve health and quality of life of patients while building trust, creating shared value and making a positive impact as a responsible corporate citizen.
Our business segments
We focus on marketing and manufacturing a broad range of products covering both hospital and consumer channels through our key business segments.
Decentralised in-country structures enable local teams to operate with entrepreneurial flair, creating value by applying local experience
12.9% Shareholding by management
Manufactured 225 million COVID vaccines, signed an African vaccine access agreement with The Serum Institute and a Human Insulin manufacturing agreement with Novo Nordisk for Africa.
Supplied 210 medicines appearing on the Essential Medicines List to 60 low to middle income countries in FY2024
Consistent inclusion in the FTSE/JSE Responsible Investment Index since 2016 and member of the FTSE4GoodIndex